Utility of dominant epitopes derived from cell-wall protein LppZ for immunodiagnostic of pulmonary tuberculosis
- PMID: 29490627
- PMCID: PMC5831716
- DOI: 10.1186/s12865-018-0243-2
Utility of dominant epitopes derived from cell-wall protein LppZ for immunodiagnostic of pulmonary tuberculosis
Abstract
Background: Serological antibodies tests for tuberculosis (TB) are widely used in developing countries. They appear to have some advantages- faster, simple and could be used for extrapulmonary TB. However, most of current commercial TB serological tests are failed to provide sufficient sensitivity and specificity. Improved serological biomarkers were essential. In this study, we present an approach using peptide array to discover new immunodiagnostic biomarkers based on immunodominant epitopes of TB antigens.
Results: The Probable conserved lipoprotein LppZ, which is difficult to express and purify in vivo was selected as the model antigen. We use two-step screening for dominant epitope selection. Based on peptide array data from 170 TB patients and 41 control samples, two dominant epitopes were identified to have diagnostic value for TB patients. Truncation assay was used to identify the core reactive sequence. Peptide- based ELISA was used to evaluate the diagnostic ability of pep-LppZ-1 and pep-LppZ-13. Pep-LppZ-1 has a sensitivity of 49.2% and a specificity of 83.3% in TB diagnose. Pep-LppZ-13 has a sensitivity of 43.3% and a specificity of 88.5% in TB diagnose.
Conclusions: Our result demonstrated that peptide array screening would be an advantage strategy of screening TB diagnostic peptides.
Keywords: LppZ; Serologic test; Tuberculosis peptide arrays.
Conflict of interest statement
Ethics approval and consent to participate
The human serum sample used in this study were obtained from Beijing Chest Hospital Sample Bank (Beijing, China), which was approved by the ethics committee of Beijing Chest Hospital, Capital Medical University.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Figures



Similar articles
-
Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.Front Cell Infect Microbiol. 2017 Nov 30;7:495. doi: 10.3389/fcimb.2017.00495. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 29250493 Free PMC article.
-
Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium tuberculosis Infection.Front Immunol. 2019 Jan 16;9:3190. doi: 10.3389/fimmu.2018.03190. eCollection 2018. Front Immunol. 2019. PMID: 30700988 Free PMC article.
-
Identification of a novel immunodominant antigen Rv2645 from RD13 with potential as a cell-mediated immunity-based TB diagnostic agent.J Infect. 2015 Nov;71(5):534-43. doi: 10.1016/j.jinf.2015.07.011. Epub 2015 Aug 28. J Infect. 2015. PMID: 26318635
-
Development of a POC test for TB based on multiple immunodominant epitopes of M. tuberculosis specific cell-wall proteins.PLoS One. 2014 Sep 23;9(9):e106279. doi: 10.1371/journal.pone.0106279. eCollection 2014. PLoS One. 2014. PMID: 25247820 Free PMC article.
-
Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.Semin Immunol. 2018 Oct;39:88-101. doi: 10.1016/j.smim.2018.07.001. Epub 2018 Jul 7. Semin Immunol. 2018. PMID: 30327124 Review.
Cited by
-
A systematic review of potential screening biomarkers for active TB disease.J Clin Tuberc Other Mycobact Dis. 2021 Nov 5;25:100284. doi: 10.1016/j.jctube.2021.100284. eCollection 2021 Dec. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34805557 Free PMC article. Review.
-
Age-Related Immunoreactivity Profiles to Diverse Mycobacterial Antigens in BCG-Vaccinated Chinese Population.Front Immunol. 2021 Jan 29;11:608220. doi: 10.3389/fimmu.2020.608220. eCollection 2020. Front Immunol. 2021. PMID: 33584683 Free PMC article.
References
-
- Zumla A, George A, Sharma V, Herbert RHN, Baroness Masham of Ilton, Oxley A, Oliver M: The WHO 2014 global tuberculosis report--further to go. Lancet Glob Health 2015, 3:e10–e12. - PubMed
-
- TB in China: a New Epidemic of an Old Disease [http://www.theglobalist.com/tb-in-china-a-new-epidemic-of-an-old-disease/].
-
- Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D, Cunningham J, Weldingh K, Pai M. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Postgrad Med J. 2007;83:705–712. doi: 10.1136/thx.2006.075754. - DOI - PMC - PubMed
-
- Yang Y, Wu X, Liu Y, Wang Z, Zhao W, Zhang J, Liang Y, Zhang C, Li H, Wang L. Letter to editor: comparative evaluation of four commercial serological antibody detection kits for the diagnosis of tuberculosis in China. Ann Clin Lab Sci. 2013;43:101–104. - PubMed
-
- Steingart KR, Flores LL, Dendukuri N, Schiller I, Laal S, Ramsay A, Hopewell PC, Pai M. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med. 2011;8:e1001062. doi: 10.1371/journal.pmed.1001062. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous